研究动态
Articles below are published ahead of final publication in an issue. Please cite articles in the following format: authors, (year), title, journal, DOI.

MiR-137介导的TIGD1高表达促进肺腺癌的迁移、侵袭并抑制细胞凋亡。

MiR-137 mediated high expression of TIGD1 promotes migration, invasion, and suppresses apoptosis of lung adenocarcinoma.

发表日期:2024 Aug 05
作者: Yiqun Wei, Runmiao Wu, Shuanying Yang, Yanfei Cao, Jing Li, Huihui Ma, Junfang Wu, Jinjin Duan, Shumei Yang
来源: LUNG CANCER

摘要:

Tigger 转座元件衍生 1 (TIGD1) 在肺腺癌 (LUAD) 中的表达及其潜在功能和调节机制仍不清楚。因此,我们打算探讨TIGD1在LUAD中的表达、潜在功能和调控机制。通过组织微阵列的免疫组织化学分析来测定LUAD组织中TIGD1的表达。进行功能实验以确定 TIGD1 如何影响 LUAD 肿瘤发生和转移。确定了TIGD1诱导LUAD进展的分子机制。TIGD1在LUAD组织中表达上调,并与淋巴结转移相关。 TIGD1 敲低抑制 LUAD 细胞增殖、迁移和侵袭,同时促进细胞凋亡。此外,在 TIGD1 敲低小鼠转移模型中观察到转移结节减少。此外,进行微阵列分析以确定 LUAD 中 TIGD1 的潜在下游基因。 Hallmark 通路分析显示 TIGD1 的下游基因参与上皮间质转化 (EMT)。 Western blotting证实波形蛋白和TWIST在TIGD1敲除细胞中表达下调,而E-钙粘蛋白表达上调。 Ingenuity 通路和标志通路分析表明,TIGD1 调节 IL-6 信号通路和相关基因成员。 Western blotting、实时定量聚合酶链反应、酶联免疫吸附测定表明,下调 TIGD1 会降低 IL-6 和 CXCL1 的表达。 TIGD1 表达与 LUAD 中的免疫浸润呈负相关。预测了TIGD1的上游microRNA,随后的荧光素酶报告基因实验证实了miR-137和TIGD1之间的相互作用。 miR-137的表达在LUAD组织中显着下调,并且miR-137部分通过负调节TIGD1的表达抑制LUAD细胞的增殖、迁移和侵袭。我们的研究结果表明TIGD1受miR-137调节,通过促进细胞增殖、迁移、侵袭和 EMT 以及抑制细胞凋亡,促进 LUAD 进展。版权所有 © 2024。由 Elsevier B.V. 出版。
Tigger transposable element-derived 1 (TIGD1) expression and its underlying functions and regulatory mechanisms in lung adenocarcinoma (LUAD) remain unknown. Therefore, we intended to explore the expression, potential functions, and regulatory mechanisms of TIGD1 in LUAD.TIGD1 expression in LUAD tissues was determined by immunohistochemistry analysis of a tissue microarray. Functional experiments were conducted to determine how TIGD1 affects LUAD tumorigenesis and metastasis. The molecular mechanisms by which TIGD1 induces LUAD progression were determined.TIGD1 was upregulated in LUAD tissues and was related to lymph node metastases. TIGD1 knockdown suppressed LUAD cell proliferation, migration, and invasion, while promoted cell apoptosis. Furthermore, decreased metastatic nodules were observed in the TIGD1 knockdown mouse metastasis model. Moreover, microarray analysis was performed to determine the potential downstream genes of TIGD1 in LUAD. Hallmark pathway analysis revealed that the downstream genes of TIGD1 were involved in epithelial-mesenchymal transition (EMT). Western blotting confirmed that vimentin and TWIST was downregulated in TIGD1 knockdown cells, while E-cadherin was upregulated. Ingenuity pathway and hallmark pathway analyses revealed that TIGD1 regulated the interleukin-6 signaling pathway and related gene members. Western blotting, quantitative real-time polymerase chain reaction, enzyme-linked immunosorbent assay indicated that downregulation of TIGD1 decreased interleukin-6 and CXCL1 expression. TIGD1 expression was negatively correlated with immune infiltration in LUAD. The upstream microRNA of TIGD1 was predicted, and subsequent luciferase reporter gene experiments confirmed the interactions between miR-137 and TIGD1. The expression of miR-137 was significantly downregulated in LUAD tissues and miR-137 suppressed the proliferation, migration, and invasion of LUAD cells, partially through negatively regulating the expression of TIGD1.Our findings suggest that TIGD1, which was regulated by miR-137, contributed to LUAD progression by promoting cell proliferation, migration, invasion, and EMT and suppressing cell apoptosis.Copyright © 2024. Published by Elsevier B.V.